CA1237999A - Antibiotiques m43a, m43b, m43c et m43d - Google Patents

Antibiotiques m43a, m43b, m43c et m43d

Info

Publication number: CA1237999A
Authority: CA; Canada
Prior art keywords: vancomycin; weight; acceptable salt; less; pharmaceutically acceptable
Prior art date: 1985-04-15
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

CA000479117A

Other languages

English (en)

Inventor

Kurt E. Merkel

Karl H. Michel

Harvey M. Higgins, Jr.

Mack H. Mccormick

Ramakrishnan Nagarajan

Marvin M. Hoehn

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Eli Lilly and Co

Original Assignee

Eli Lilly and Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-04-15

Filing date

1985-04-15

Publication date

1988-06-14

1985-04-15 Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co

1985-04-15 Priority to CA000479117A priority Critical patent/CA1237999A/fr

1988-06-14 Application granted granted Critical

1988-06-14 Publication of CA1237999A publication Critical patent/CA1237999A/fr

Status Expired legal-status Critical Current

Links

239000003242 anti bacterial agent Substances 0.000 title abstract description 22
229940088710 antibiotic agent Drugs 0.000 title abstract description 22
MYPYJXKWCTUITO-KIIOPKALSA-N chembl3301825 Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)C(O)[C@H](C)O1 MYPYJXKWCTUITO-KIIOPKALSA-N 0.000 claims abstract description 20
102220597425 G0/G1 switch protein 2_M43A_mutation Human genes 0.000 claims abstract description 12
241001430312 Amycolatopsis orientalis Species 0.000 claims abstract 2
150000003839 salts Chemical class 0.000 claims description 52
230000003115 biocidal effect Effects 0.000 claims description 41
108010059993 Vancomycin Proteins 0.000 claims description 31
229960003165 vancomycin Drugs 0.000 claims description 31
MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 claims description 30
238000000034 method Methods 0.000 claims description 27
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 18
238000004519 manufacturing process Methods 0.000 claims description 14
239000000126 substance Substances 0.000 claims description 14
125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims description 10
239000001963 growth medium Substances 0.000 claims description 10
238000000926 separation method Methods 0.000 claims description 8
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 6
239000004480 active ingredient Substances 0.000 claims description 5
239000003937 drug carrier Substances 0.000 claims description 5
239000008194 pharmaceutical composition Substances 0.000 claims description 5
238000010564 aerobic fermentation Methods 0.000 claims description 4
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 3
229910052799 carbon Inorganic materials 0.000 claims description 3
229910052757 nitrogen Inorganic materials 0.000 claims description 3
MYPYJXKWCTUITO-LYRMYLQWSA-O vancomycin(1+) Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C([O-])=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)[NH2+]C)[C@H]1C[C@](C)([NH3+])[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-O 0.000 claims 10
125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 6
239000003085 diluting agent Substances 0.000 claims 4
125000000896 monocarboxylic acid group Chemical group 0.000 claims 3
MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical class O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 abstract description 23
238000000855 fermentation Methods 0.000 abstract description 8
230000004151 fermentation Effects 0.000 abstract description 8
230000000844 anti-bacterial effect Effects 0.000 abstract description 2
239000003910 polypeptide antibiotic agent Substances 0.000 abstract 1
235000002639 sodium chloride Nutrition 0.000 description 30
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 29
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 25
239000000203 mixture Substances 0.000 description 22
229910001868 water Inorganic materials 0.000 description 18
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
241000191940 Staphylococcus Species 0.000 description 14
239000000243 solution Substances 0.000 description 13
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 10
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 10
230000000694 effects Effects 0.000 description 10
241000588722 Escherichia Species 0.000 description 9
239000002253 acid Substances 0.000 description 9
238000004128 high performance liquid chromatography Methods 0.000 description 9
239000002609 medium Substances 0.000 description 9
239000011347 resin Substances 0.000 description 9
229920005989 resin Polymers 0.000 description 9
239000004615 ingredient Substances 0.000 description 8
239000000725 suspension Substances 0.000 description 8
239000008103 glucose Substances 0.000 description 7
238000002360 preparation method Methods 0.000 description 7
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
241000194017 Streptococcus Species 0.000 description 6
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
238000007792 addition Methods 0.000 description 6
239000012530 fluid Substances 0.000 description 6
229920000168 Microcrystalline cellulose Polymers 0.000 description 5
235000018936 Vitellaria paradoxa Nutrition 0.000 description 5
229910000147 aluminium phosphate Inorganic materials 0.000 description 5
238000003556 assay Methods 0.000 description 5
238000004587 chromatography analysis Methods 0.000 description 5
238000009472 formulation Methods 0.000 description 5
206010022000 influenza Diseases 0.000 description 5
238000001990 intravenous administration Methods 0.000 description 5
235000019813 microcrystalline cellulose Nutrition 0.000 description 5
239000008108 microcrystalline cellulose Substances 0.000 description 5
229940016286 microcrystalline cellulose Drugs 0.000 description 5
229920000036 polyvinylpyrrolidone Polymers 0.000 description 5
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 5
239000000843 powder Substances 0.000 description 5
239000013587 production medium Substances 0.000 description 5
239000002904 solvent Substances 0.000 description 5
229920002261 Corn starch Polymers 0.000 description 4
229920002785 Croscarmellose sodium Polymers 0.000 description 4
WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 4
241000187654 Nocardia Species 0.000 description 4
DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 4
239000007864 aqueous solution Substances 0.000 description 4
150000001875 compounds Chemical class 0.000 description 4
239000008120 corn starch Substances 0.000 description 4
229960001681 croscarmellose sodium Drugs 0.000 description 4
235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 description 4
239000008367 deionised water Substances 0.000 description 4
229910021641 deionized water Inorganic materials 0.000 description 4
238000001514 detection method Methods 0.000 description 4
238000010265 fast atom bombardment Methods 0.000 description 4
-1 for example Chemical class 0.000 description 4
230000001965 increasing effect Effects 0.000 description 4
239000002054 inoculum Substances 0.000 description 4
238000002955 isolation Methods 0.000 description 4
239000000463 material Substances 0.000 description 4
235000013336 milk Nutrition 0.000 description 4
210000004080 milk Anatomy 0.000 description 4
239000012071 phase Substances 0.000 description 4
229940069328 povidone Drugs 0.000 description 4
241000283690 Bos taurus Species 0.000 description 3
240000007124 Brassica oleracea Species 0.000 description 3
235000003899 Brassica oleracea var acephala Nutrition 0.000 description 3
235000012905 Brassica oleracea var viridis Nutrition 0.000 description 3
239000004375 Dextrin Substances 0.000 description 3
229920001353 Dextrin Polymers 0.000 description 3
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
241000194031 Enterococcus faecium Species 0.000 description 3
201000008225 Klebsiella pneumonia Diseases 0.000 description 3
241000588747 Klebsiella pneumoniae Species 0.000 description 3
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
241001465754 Metazoa Species 0.000 description 3
206010035717 Pneumonia klebsiella Diseases 0.000 description 3
241000282849 Ruminantia Species 0.000 description 3
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
241000191963 Staphylococcus epidermidis Species 0.000 description 3
229920002472 Starch Polymers 0.000 description 3
235000019425 dextrin Nutrition 0.000 description 3
239000001177 diphosphate Substances 0.000 description 3
XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 3
235000011180 diphosphates Nutrition 0.000 description 3
239000012153 distilled water Substances 0.000 description 3
239000000706 filtrate Substances 0.000 description 3
238000000338 in vitro Methods 0.000 description 3
208000015181 infectious disease Diseases 0.000 description 3
239000011777 magnesium Substances 0.000 description 3
229910052749 magnesium Inorganic materials 0.000 description 3
230000014759 maintenance of location Effects 0.000 description 3
244000005700 microbiome Species 0.000 description 3
239000003921 oil Substances 0.000 description 3
235000019198 oils Nutrition 0.000 description 3
239000002245 particle Substances 0.000 description 3
229920000642 polymer Polymers 0.000 description 3
229920001296 polysiloxane Polymers 0.000 description 3
239000000047 product Substances 0.000 description 3
239000007787 solid Substances 0.000 description 3
239000008107 starch Substances 0.000 description 3
235000019698 starch Nutrition 0.000 description 3
229940032147 starch Drugs 0.000 description 3
238000012360 testing method Methods 0.000 description 3
IJSNCWAAHIVVGJ-XVMARJQXSA-N (3s,4s,5s)-3-amino-4,5-dihydroxy-3-methylhexanal Chemical compound C[C@H](O)[C@@H](O)[C@@](C)(N)CC=O IJSNCWAAHIVVGJ-XVMARJQXSA-N 0.000 description 2
QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 2
QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
208000035143 Bacterial infection Diseases 0.000 description 2
241000606125 Bacteroides Species 0.000 description 2
241000606124 Bacteroides fragilis Species 0.000 description 2
241000193403 Clostridium Species 0.000 description 2
230000005526 G1 to G0 transition Effects 0.000 description 2
241001441571 Hiodontidae Species 0.000 description 2
XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
241000282320 Panthera leo Species 0.000 description 2
241001135223 Prevotella melaninogenica Species 0.000 description 2
240000004808 Saccharomyces cerevisiae Species 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
235000019764 Soybean Meal Nutrition 0.000 description 2
108700013560 Staphylococcus epidermidis EpiC Proteins 0.000 description 2
101100118959 Staphylococcus epidermidis epiC gene Proteins 0.000 description 2
229930006000 Sucrose Natural products 0.000 description 2
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
208000035896 Twin-reversed arterial perfusion sequence Diseases 0.000 description 2
OIJZDPGKNVKVBL-UHFFFAOYSA-N Vancosamine Natural products CC1OC(O)CC(C)(N)C1O OIJZDPGKNVKVBL-UHFFFAOYSA-N 0.000 description 2
150000007513 acids Chemical class 0.000 description 2
238000002814 agar dilution Methods 0.000 description 2
235000010443 alginic acid Nutrition 0.000 description 2
239000000783 alginic acid Substances 0.000 description 2
229920000615 alginic acid Polymers 0.000 description 2
229960001126 alginic acid Drugs 0.000 description 2
150000004781 alginic acids Chemical class 0.000 description 2
239000008346 aqueous phase Substances 0.000 description 2
230000001580 bacterial effect Effects 0.000 description 2
208000022362 bacterial infectious disease Diseases 0.000 description 2
239000002585 base Substances 0.000 description 2
235000015278 beef Nutrition 0.000 description 2
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
239000002775 capsule Substances 0.000 description 2
UNXNGGMLCSMSLH-UHFFFAOYSA-N dihydrogen phosphate;triethylazanium Chemical compound OP(O)(O)=O.CCN(CC)CC UNXNGGMLCSMSLH-UHFFFAOYSA-N 0.000 description 2
239000002552 dosage form Substances 0.000 description 2
238000001704 evaporation Methods 0.000 description 2
230000008020 evaporation Effects 0.000 description 2
239000012458 free base Substances 0.000 description 2
239000012535 impurity Substances 0.000 description 2
238000001802 infusion Methods 0.000 description 2
239000008267 milk Substances 0.000 description 2
235000013379 molasses Nutrition 0.000 description 2
229910000402 monopotassium phosphate Inorganic materials 0.000 description 2
239000000546 pharmaceutical excipient Substances 0.000 description 2
239000002504 physiological saline solution Substances 0.000 description 2
230000001737 promoting effect Effects 0.000 description 2
QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
239000000741 silica gel Substances 0.000 description 2
229910002027 silica gel Inorganic materials 0.000 description 2
238000001179 sorption measurement Methods 0.000 description 2
239000004455 soybean meal Substances 0.000 description 2
238000001228 spectrum Methods 0.000 description 2
239000005720 sucrose Substances 0.000 description 2
235000020357 syrup Nutrition 0.000 description 2
239000006188 syrup Substances 0.000 description 2
235000013619 trace mineral Nutrition 0.000 description 2
239000011573 trace mineral Substances 0.000 description 2
238000011282 treatment Methods 0.000 description 2
241001148471 unidentified anaerobic bacterium Species 0.000 description 2
239000003981 vehicle Substances 0.000 description 2
239000008215 water for injection Substances 0.000 description 2
DQJCDTNMLBYVAY-ZXXIYAEKSA-N (2S,5R,10R,13R)-16-{[(2R,3S,4R,5R)-3-{[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-(ethylamino)-6-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxy}-5-(4-aminobutyl)-10-carbamoyl-2,13-dimethyl-4,7,12,15-tetraoxo-3,6,11,14-tetraazaheptadecan-1-oic acid Chemical group NCCCC[C@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)CC[C@H](C(N)=O)NC(=O)[C@@H](C)NC(=O)C(C)O[C@@H]1[C@@H](NCC)C(O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O)[C@@H](CO)O1 DQJCDTNMLBYVAY-ZXXIYAEKSA-N 0.000 description 1
NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
208000004998 Abdominal Pain Diseases 0.000 description 1
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
239000005995 Aluminium silicate Substances 0.000 description 1
QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
ZAPPZUOJTISCRA-UHFFFAOYSA-N Antibiotic M 43D Natural products CC(C)CC([NH+](C)C)C(=O)NC1C(O)c2ccc(Oc3cc4cc(Oc5ccc(cc5Cl)C(O)C6NC(=O)C(NC(O)C4NC(=O)C(CC(=O)N)NC1=O)c7ccc(O)c(c7)c8c(O)cc(O)cc8C(NC6=O)C(=O)[O-])c3OC9OC(CO)C(O)C(O)C9OC%10CC(C)(N)C(O)C(C)O%10)c(Cl)c2 ZAPPZUOJTISCRA-UHFFFAOYSA-N 0.000 description 1
241000193830 Bacillus <bacterium> Species 0.000 description 1
241000606123 Bacteroides thetaiotaomicron Species 0.000 description 1
241000167854 Bourreria succulenta Species 0.000 description 1
COVZYZSDYWQREU-UHFFFAOYSA-N Busulfan Chemical compound CS(=O)(=O)OCCCCOS(C)(=O)=O COVZYZSDYWQREU-UHFFFAOYSA-N 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
241001342895 Chorus Species 0.000 description 1
208000002881 Colic Diseases 0.000 description 1
241001262170 Collinsella aerofaciens Species 0.000 description 1
208000035473 Communicable disease Diseases 0.000 description 1
102000003712 Complement factor B Human genes 0.000 description 1
108090000056 Complement factor B Proteins 0.000 description 1
235000019739 Dicalciumphosphate Nutrition 0.000 description 1
241001050985 Disco Species 0.000 description 1
102000004190 Enzymes Human genes 0.000 description 1
108090000790 Enzymes Proteins 0.000 description 1
239000001856 Ethyl cellulose Substances 0.000 description 1
ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
241000192125 Firmicutes Species 0.000 description 1
241000605909 Fusobacterium Species 0.000 description 1
241000605952 Fusobacterium necrophorum Species 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
244000068988 Glycine max Species 0.000 description 1
235000010469 Glycine max Nutrition 0.000 description 1
108010015899 Glycopeptides Proteins 0.000 description 1
102000002068 Glycopeptides Human genes 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
241001424413 Lucia Species 0.000 description 1
244000246386 Mentha pulegium Species 0.000 description 1
235000016257 Mentha pulegium Nutrition 0.000 description 1
235000004357 Mentha x piperita Nutrition 0.000 description 1
241000699670 Mus sp. Species 0.000 description 1
238000005481 NMR spectroscopy Methods 0.000 description 1
229910002651 NO3 Inorganic materials 0.000 description 1
NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
241001494479 Pecora Species 0.000 description 1
241000364057 Peoria Species 0.000 description 1
241000206591 Peptococcus Species 0.000 description 1
241000192013 Peptoniphilus asaccharolyticus Species 0.000 description 1
241000191992 Peptostreptococcus Species 0.000 description 1
241000192035 Peptostreptococcus anaerobius Species 0.000 description 1
241000644027 Perideridia lemmonii Species 0.000 description 1
240000007377 Petunia x hybrida Species 0.000 description 1
206010035664 Pneumonia Diseases 0.000 description 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
241000186429 Propionibacterium Species 0.000 description 1
208000003251 Pruritus Diseases 0.000 description 1
229920005654 Sephadex Polymers 0.000 description 1
239000012507 Sephadex™ Substances 0.000 description 1
235000017899 Spathodea campanulata Nutrition 0.000 description 1
201000005010 Streptococcus pneumonia Diseases 0.000 description 1
241000193998 Streptococcus pneumoniae Species 0.000 description 1
241000187747 Streptomyces Species 0.000 description 1
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
241000282898 Sus scrofa Species 0.000 description 1
238000002441 X-ray diffraction Methods 0.000 description 1
240000008042 Zea mays Species 0.000 description 1
235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
235000002017 Zea mays subsp mays Nutrition 0.000 description 1
239000003463 adsorbent Substances 0.000 description 1
238000005273 aeration Methods 0.000 description 1
235000012211 aluminium silicate Nutrition 0.000 description 1
125000003277 amino group Chemical group 0.000 description 1
235000012538 ammonium bicarbonate Nutrition 0.000 description 1
VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 description 1
239000003708 ampul Substances 0.000 description 1
230000000845 anti-microbial effect Effects 0.000 description 1
239000002518 antifoaming agent Substances 0.000 description 1
238000013459 approach Methods 0.000 description 1
244000052616 bacterial pathogen Species 0.000 description 1
WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid group Chemical group C(C1=CC=CC=C1)(=O)O WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
239000011230 binding agent Substances 0.000 description 1
239000008280 blood Substances 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
230000037396 body weight Effects 0.000 description 1
239000012267 brine Substances 0.000 description 1
239000011575 calcium Substances 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
239000001506 calcium phosphate Substances 0.000 description 1
229940041514 candida albicans extract Drugs 0.000 description 1
239000007963 capsule composition Substances 0.000 description 1
150000001720 carbohydrates Chemical class 0.000 description 1
235000014633 carbohydrates Nutrition 0.000 description 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
239000000969 carrier Substances 0.000 description 1
239000003729 cation exchange resin Substances 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
235000019693 cherries Nutrition 0.000 description 1
239000008119 colloidal silica Substances 0.000 description 1
239000003086 colorant Substances 0.000 description 1
239000013065 commercial product Substances 0.000 description 1
239000012141 concentrate Substances 0.000 description 1
235000008504 concentrate Nutrition 0.000 description 1
230000001143 conditioned effect Effects 0.000 description 1
239000000470 constituent Substances 0.000 description 1
239000012059 conventional drug carrier Substances 0.000 description 1
235000005822 corn Nutrition 0.000 description 1
229940099112 cornstarch Drugs 0.000 description 1
235000012343 cottonseed oil Nutrition 0.000 description 1
238000002425 crystallisation Methods 0.000 description 1
230000008025 crystallization Effects 0.000 description 1
238000012258 culturing Methods 0.000 description 1
HAORKNGNJCEJBX-UHFFFAOYSA-N cyprodinil Chemical compound N=1C(C)=CC(C2CC2)=NC=1NC1=CC=CC=C1 HAORKNGNJCEJBX-UHFFFAOYSA-N 0.000 description 1
QCHYVJAUGVHJHX-UHFFFAOYSA-N desvancosamine-vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1O QCHYVJAUGVHJHX-UHFFFAOYSA-N 0.000 description 1
238000011161 development Methods 0.000 description 1
239000008121 dextrose Substances 0.000 description 1
NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
229940038472 dicalcium phosphate Drugs 0.000 description 1
229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
239000011363 dried mixture Substances 0.000 description 1
230000002708 enhancing effect Effects 0.000 description 1
230000002255 enzymatic effect Effects 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
235000019325 ethyl cellulose Nutrition 0.000 description 1
229920001249 ethyl cellulose Polymers 0.000 description 1
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
230000029142 excretion Effects 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
239000000284 extract Substances 0.000 description 1
238000001914 filtration Methods 0.000 description 1
239000000796 flavoring agent Substances 0.000 description 1
238000005187 foaming Methods 0.000 description 1
235000013355 food flavoring agent Nutrition 0.000 description 1
239000012634 fragment Substances 0.000 description 1
239000000499 gel Substances 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
239000007903 gelatin capsule Substances 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
239000011521 glass Substances 0.000 description 1
239000008187 granular material Substances 0.000 description 1
238000003306 harvesting Methods 0.000 description 1
210000003128 head Anatomy 0.000 description 1
235000001050 hortel pimenta Nutrition 0.000 description 1
239000000413 hydrolysate Substances 0.000 description 1
239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
238000011534 incubation Methods 0.000 description 1
210000001785 incus Anatomy 0.000 description 1
230000002401 inhibitory effect Effects 0.000 description 1
230000005764 inhibitory process Effects 0.000 description 1
238000010565 inoculated fermentation Methods 0.000 description 1
238000011081 inoculation Methods 0.000 description 1
229910052500 inorganic mineral Inorganic materials 0.000 description 1
230000010354 integration Effects 0.000 description 1
238000007918 intramuscular administration Methods 0.000 description 1
239000003456 ion exchange resin Substances 0.000 description 1
229920003303 ion-exchange polymer Polymers 0.000 description 1
150000002500 ions Chemical class 0.000 description 1
229910052742 iron Inorganic materials 0.000 description 1
NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
239000008101 lactose Substances 0.000 description 1
235000010445 lecithin Nutrition 0.000 description 1
239000000787 lecithin Substances 0.000 description 1
229940067606 lecithin Drugs 0.000 description 1
150000004668 long chain fatty acids Chemical class 0.000 description 1
239000000314 lubricant Substances 0.000 description 1
NEMFQSKAPLGFIP-UHFFFAOYSA-N magnesiosodium Chemical compound [Na].[Mg] NEMFQSKAPLGFIP-UHFFFAOYSA-N 0.000 description 1
235000012054 meals Nutrition 0.000 description 1
235000013372 meat Nutrition 0.000 description 1
239000012528 membrane Substances 0.000 description 1
230000004060 metabolic process Effects 0.000 description 1
229920000609 methyl cellulose Polymers 0.000 description 1
OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 1
239000001923 methylcellulose Substances 0.000 description 1
235000010981 methylcellulose Nutrition 0.000 description 1
229910052618 mica group Inorganic materials 0.000 description 1
235000010755 mineral Nutrition 0.000 description 1
239000011707 mineral Substances 0.000 description 1
150000007522 mineralic acids Chemical class 0.000 description 1
239000006151 minimal media Substances 0.000 description 1
238000002156 mixing Methods 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
239000011664 nicotinic acid Substances 0.000 description 1
238000010606 normalization Methods 0.000 description 1
235000015097 nutrients Nutrition 0.000 description 1
150000007524 organic acids Chemical class 0.000 description 1
238000012856 packing Methods 0.000 description 1
238000007911 parenteral administration Methods 0.000 description 1
239000008188 pellet Substances 0.000 description 1
229940074571 peptostreptococcus anaerobius Drugs 0.000 description 1
150000002989 phenols Chemical class 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
235000021178 picnic Nutrition 0.000 description 1
229920001451 polypropylene glycol Polymers 0.000 description 1
239000001267 polyvinylpyrrolidone Substances 0.000 description 1
239000011591 potassium Substances 0.000 description 1
229910052700 potassium Inorganic materials 0.000 description 1
244000144977 poultry Species 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
238000011321 prophylaxis Methods 0.000 description 1
235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
229960003415 propylparaben Drugs 0.000 description 1
108090000623 proteins and genes Proteins 0.000 description 1
102000004169 proteins and genes Human genes 0.000 description 1
239000008213 purified water Substances 0.000 description 1
238000011160 research Methods 0.000 description 1
238000004366 reverse phase liquid chromatography Methods 0.000 description 1
230000035945 sensitivity Effects 0.000 description 1
238000012807 shake-flask culturing Methods 0.000 description 1
239000011734 sodium Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
229960002668 sodium chloride Drugs 0.000 description 1
239000001509 sodium citrate Substances 0.000 description 1
NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
239000008109 sodium starch glycolate Substances 0.000 description 1
229940079832 sodium starch glycolate Drugs 0.000 description 1
229920003109 sodium starch glycolate Polymers 0.000 description 1
WSWCOQWTEOXDQX-MQQKCMAXSA-N sorbic acid group Chemical group C(\C=C\C=C\C)(=O)O WSWCOQWTEOXDQX-MQQKCMAXSA-N 0.000 description 1
229910001220 stainless steel Inorganic materials 0.000 description 1
239000010935 stainless steel Substances 0.000 description 1
238000010561 standard procedure Methods 0.000 description 1
238000003756 stirring Methods 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
239000007916 tablet composition Substances 0.000 description 1
239000000454 talc Substances 0.000 description 1
229910052623 talc Inorganic materials 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
229960001572 vancomycin hydrochloride Drugs 0.000 description 1
LCTORFDMHNKUSG-XTTLPDOESA-N vancomycin monohydrochloride Chemical compound Cl.O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 LCTORFDMHNKUSG-XTTLPDOESA-N 0.000 description 1
235000012431 wafers Nutrition 0.000 description 1
239000001993 wax Substances 0.000 description 1
239000009637 wintergreen oil Substances 0.000 description 1
239000012138 yeast extract Substances 0.000 description 1

Landscapes

Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

CA000479117A 1985-04-15 1985-04-15 Antibiotiques m43a, m43b, m43c et m43d Expired CA1237999A (fr)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
CA000479117A CA1237999A (fr)	1985-04-15	1985-04-15	Antibiotiques m43a, m43b, m43c et m43d

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CA000479117A CA1237999A (fr)	1985-04-15	1985-04-15	Antibiotiques m43a, m43b, m43c et m43d

Publications (1)

Publication Number	Publication Date
CA1237999A true CA1237999A (fr)	1988-06-14

Family

ID=4130264

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA000479117A Expired CA1237999A (fr)	1985-04-15	1985-04-15	Antibiotiques m43a, m43b, m43c et m43d

Country Status (1)

Country	Link
CA (1)	CA1237999A (fr)

1985
- 1985-04-15 CA CA000479117A patent/CA1237999A/fr not_active Expired

Legal Events

Date	Code	Title	Description
2005-06-14	MKEX	Expiry

Publication	Publication Date	Title
EP0265071B1 (fr)	1992-11-19	Antibiotiques glycopeptidiques
US4547488A (en)	1985-10-15	Antibiotic M43D, pharmaceutical compositions and method of use
EP0100605B1 (fr)	1986-10-15	Antibiotique A47934 et sa production
US5391492A (en)	1995-02-21	A83850 antibiotics
US4918054A (en)	1990-04-17	Antibiotics called `chloropolysporins B and C`, a process for their preparation, and their therapeutic and veterinary use
EP0287110B1 (fr)	1994-03-02	Antibiotiques glycopeptidiques pa-45052
US4548974A (en)	1985-10-22	Antibiotics produced by Kibdelosporangium aridum shearer
EP0159180B1 (fr)	1989-08-09	Antibiotiques M43A, M43B, M43C et M43D
US4548925A (en)	1985-10-22	Antibiotic M43A, pharmaceutical composition and method of use
EP0306645B1 (fr)	1993-11-03	Dérivés ressemblant à la teicoplanine
US4548924A (en)	1985-10-22	Antibiotics M43B and M43C, pharmaceutical composition and method of use
CA1237999A (fr)	1988-06-14	Antibiotiques m43a, m43b, m43c et m43d
CA1212060A (fr)	1986-09-30	Chloropolysporine antibiotique, procede de preparation et usages therapeutiques et veterinaires
DK167688B1 (da)	1993-12-06	Antibiotika benaevnt a51568 faktor a og b, en fremgangsmaade til fremstilling heraf, mikroorganismen nocardia orientalis nrrl 15232 til brug ved fremgangsmaaden, farmaceutiske praeparater indeholdende saadanne antibiotika samt anvendelse af disse antibiotika som antibiotiske midler
US4672036A (en)	1987-06-09	Pure cultures of Kibdelsporangium aridum Shearer gen. nov., sp. nov. ATCC 39323 and mutants thereof
EP0211490B1 (fr)	1992-02-26	Antibiotiques appartenant au groupe des vancomycines
KR100199650B1 (ko)	1999-06-15	신규 만노실 테이코플라닌 아글리콘 및 만노실 테이코플라닌유도체의 제조방법
EP0055071A1 (fr)	1982-06-30	L'antibiotique A-4696, facteur G
EP0150565A1 (fr)	1985-08-07	L'antibiotique glycopeptide CUC/CSV et son procédé de préparation
US4996148A (en)	1991-02-26	A80407 antibiotics
US5213797A (en)	1993-05-25	A80407 antibiotics
US4663282A (en)	1987-05-05	Glycopeptide antibiotic CUC/CSV and process for its production
CS228936B2 (cs)	1984-05-14	Předběžné, respektive doplňkové krmivo pra vytvoření krmivá pro hospodářská zvířata, zvláště přežvýkavco